Richard A. Heyman - Director at Oric Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
ORIC on Nasdaq
All Insider Reports
All Insider Reports

Richard A. Heyman - trading volume in the past year for Oric Pharmaceuticals, Inc.

Holdings reported by Richard A. Heyman for Oric Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 213,072 $2,557,844 $12.00 16 Jan 2026 Indirect
Common Stock 41,800 $501,792 $12.00 16 Jan 2026 Direct
Stock Option (right to buy) 40,000 02 Jan 2026 Direct Common Stock

Transactions reported by Richard A. Heyman for Oric Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.